Glycemic Status and Infection Risk in Nondiabetic Autologous Hematopoietic Cell Transplantation Recipients

Biological Research for Nursing
Marilyn J HammerCharles M Cleland

Abstract

Patients undergoing hematopoietic cell transplantation (HCT) for hematological malignancies experience a number of challenges during treatment. There is growing evidence that malglycemia (hyperglycemia, hypoglycemia, and/or increased glycemic variability) contributes to HCT-related complications, even in patients without preexisting diabetes. The purpose of this pilot study was to investigate factors influencing glycemic status and associated infection occurrences in nondiabetic autologous HCT recipients. Oncology patients without preexisting diabetes treated with autologous HCT at a National Cancer Institute-designated cancer center were followed from admission through discharge or 28 days post-HCT. Patients had morning fasting laboratory tests. Descriptive statistics and Cox proportional hazards models were used to examine associations between BG levels and risk for infection while adjusting for baseline covariates including age, body mass index (BMI), cumulative glucocorticoid dose, and diagnosis. The sample included 28 female and 25 male predominately non-Hispanic White patients (mean age 55.7 years, SD = 11.32). Blood glucose (BG) range was 35-325 mg/dl. Twenty-three patients incurred at least one infection. BMI ≥ 25 kg/m(...Continue Reading

References

Feb 27, 2004·Journal of Intensive Care Medicine·W Garrett Nichols
Jul 12, 2005·Pharmacotherapy·Simona O ButlerCesar Alaniz
Aug 19, 2006·Critical Care Medicine·Matthias TurinaHiram C Polk
Nov 4, 2006·Journal of Applied Physiology·Abram Katz
Aug 2, 2007·Nature Reviews. Molecular Cell Biology·Judith Campisi, Fabrizio d'Adda di Fagagna
Nov 28, 2007·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Jonathan P Godbout, Ronald Glaser
May 6, 2008·Transplantation Proceedings·F Cr MazaliM Mazzali
May 13, 2008·Nutrition·Monica Martin-SalcesFernando Hernandez-Navarro
Aug 22, 2008·Diabetes·Ian R LanzaK Sreekumaran Nair
Dec 6, 2008·The American Journal of Clinical Nutrition·Ian R Lanza, K Sreekumaran Nair
Dec 18, 2008·JAMA : the Journal of the American Medical Association·Bethany B BaroneFrederick L Brancati
Feb 11, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Marilyn J HammerIrl B Hirsch
May 19, 2009·Diabetes & Metabolism·U-M VischerUNKNOWN Alfediam/SFGG French-speaking group for study of diabetes in the elderly
May 28, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Lawrence H EinhornPetra Feyer
Jul 1, 2010·Diabetes Care·Edward GiovannucciDouglas Yee
Mar 5, 2013·The Journal of Clinical Investigation·Tamara TchkoniaJames L Kirkland
Aug 16, 2013·European Journal of Preventive Cardiology·Igor A Kelmanson
Oct 10, 2013·Journal of Diabetes·Antonio PerezRicardo Gomez-Huelgas
Aug 22, 2014·Oxidative Medicine and Cellular Longevity·Soazig Le LayRamaroson Andriantsitohaina
Aug 26, 2014·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Chiaw Ling ChngTim Beale

❮ Previous
Next ❯

Citations

Jul 20, 2018·Cancer Nursing·Marilyn J HammerChristine Miaskowski
Feb 13, 2020·Einstein·Juliana Bernardo BarbanAndrea Z Pereira

❮ Previous
Next ❯

Software Mentioned

R
_ Core _ Team
SPSS

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Marilyn J HammerIrl B Hirsch
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Paul A HoffmeisterK S Baker
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
M A OlsenE R Dubberke
© 2022 Meta ULC. All rights reserved